THE INFLUENCE OF COGNITIVE BEHAVIORAL THERAPY IN SEXUAL DYSFUNCTION FEMALE: Randomized Clinical Trial
NCT ID: NCT02613546
Last Updated: 2023-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
34 participants
INTERVENTIONAL
2015-09-10
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive behavioral therapy (CBT)
The study group will undergo 10 sessions of guidelines and cognitive behavioral therapy (CBT) about an hour long, once a week. Of these:
1. evaluation session;
2. sessions of psychoeducation about the CBT model
5 sessions of cognitive restructuring 2 sessions of preventing relapse
Cognitive behavioral therapy (CBT)
The study group will undergo 10 sessions of guidelines and cognitive behavioral therapy (CBT) about an hour long, once a week. Of these:
1. evaluation session;
2. sessions of psychoeducation about the CBT model
5 sessions of cognitive restructuring 2 sessions of preventing relapse
Control
The control group will be subjected to 10 weekly sessions (1 time per week) approximately one hour guidelines.
Control therapy
The control group will be subjected to 10 weekly sessions (1 time per week) approximately one hour guidelines.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive behavioral therapy (CBT)
The study group will undergo 10 sessions of guidelines and cognitive behavioral therapy (CBT) about an hour long, once a week. Of these:
1. evaluation session;
2. sessions of psychoeducation about the CBT model
5 sessions of cognitive restructuring 2 sessions of preventing relapse
Control therapy
The control group will be subjected to 10 weekly sessions (1 time per week) approximately one hour guidelines.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* FSFI less than or equal to 26.
Exclusion Criteria
* Prescribing hormone therapy after starting the group.
18 Years
59 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro de Atenção ao Assoalho Pélvico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patricia V Lordelo, PhD
Role: PRINCIPAL_INVESTIGATOR
Centro de Atenção ao Assoalho Pélvico - BAHIANA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centro de Atenção ao Assoalho Pelvico
Salvador, Estado de Bahia, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Patricia V Lordelo, Phd
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U1111-11754978
Identifier Type: -
Identifier Source: org_study_id